Quarterly report · Q1

Period2023-07-01 → 2023-09-30
Filed2023-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥5.8bn2023-07-01 → 2023-09-30Cons.Net sales
Revenue¥22.1bn2022-07-01 → 2023-06-30Cons.Net sales (5-year summary)
Revenue¥5.4bn2022-07-01 → 2022-09-30Cons.Net sales
Operating income¥1.2bn2023-07-01 → 2023-09-30Cons.Operating income
Operating income¥1.0bn2022-07-01 → 2022-09-30Cons.Operating income
Ordinary income¥1.2bn2023-07-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥4.1bn2022-07-01 → 2023-06-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥979m2022-07-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥1.2bn2023-07-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥979m2022-07-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥758m2023-07-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.7bn2022-07-01 → 2023-06-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥606m2022-07-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥758m2023-07-01 → 2023-09-30Cons.Profit loss
Net income¥606m2022-07-01 → 2022-09-30Cons.Profit loss
Total assets¥28.7bnat 2023-09-30Cons.Assets
Total assets¥28.5bnat 2023-06-30Cons.Assets
Total assets¥26.3bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥7.4bnat 2023-09-30Cons.Liabilities
Total liabilities¥7.5bnat 2023-06-30Cons.Liabilities
Net assets / equity¥21.2bnat 2023-09-30Cons.Net assets
Net assets / equity¥20.9bnat 2023-06-30Cons.Net assets
Net assets / equity¥18.8bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥9.6bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥10.8bnat 2023-06-30Cons.Cash and deposits
EPS (basic)¥19.122023-07-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥67.832022-07-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥15.292022-07-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio74.0%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio73.5%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio71.8%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 28
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-07-01 → 2023-09-30−¥449m
Reconciling Itemsreconcilingrevenue intersegment2023-07-01 → 2023-09-30−¥449m
Reconciling Itemsreconcilingsegment profit2023-07-01 → 2023-09-30−¥15m
jpcrp040300-q1r_E34071-000Drug Substance Sales Businessreportable segmentrevenue2023-07-01 → 2023-09-30¥4.0bn
jpcrp040300-q1r_E34071-000Drug Substance Sales Businessreportable segmentrevenue external2023-07-01 → 2023-09-30¥3.6bn
jpcrp040300-q1r_E34071-000Drug Substance Sales Businessreportable segmentrevenue intersegment2023-07-01 → 2023-09-30¥449m
jpcrp040300-q1r_E34071-000Drug Substance Sales Businessreportable segmentsegment profit2023-07-01 → 2023-09-30¥686m
jpcrp040300-q1r_E34071-000Pharmaceutical Marketing Businessreportable segmentrevenue2023-07-01 → 2023-09-30¥2.2bn
jpcrp040300-q1r_E34071-000Pharmaceutical Marketing Businessreportable segmentrevenue external2023-07-01 → 2023-09-30¥2.2bn
jpcrp040300-q1r_E34071-000Pharmaceutical Marketing Businessreportable segmentsegment profit2023-07-01 → 2023-09-30¥526m
—segment totalrevenue2023-07-01 → 2023-09-30¥6.3bn
—segment totalrevenue external2023-07-01 → 2023-09-30¥5.8bn
—segment totalrevenue intersegment2023-07-01 → 2023-09-30¥449m
—segment totalsegment profit2023-07-01 → 2023-09-30¥1.2bn
Reconciling Itemsreconcilingrevenue2022-07-01 → 2022-09-30−¥501m
Reconciling Itemsreconcilingrevenue intersegment2022-07-01 → 2022-09-30−¥501m
Reconciling Itemsreconcilingsegment profit2022-07-01 → 2022-09-30¥6m
jpcrp040300-q1r_E34071-000Drug Substance Sales Businessreportable segmentrevenue2022-07-01 → 2022-09-30¥4.0bn
jpcrp040300-q1r_E34071-000Drug Substance Sales Businessreportable segmentrevenue external2022-07-01 → 2022-09-30¥3.5bn
jpcrp040300-q1r_E34071-000Drug Substance Sales Businessreportable segmentrevenue intersegment2022-07-01 → 2022-09-30¥501m
jpcrp040300-q1r_E34071-000Drug Substance Sales Businessreportable segmentsegment profit2022-07-01 → 2022-09-30¥672m
jpcrp040300-q1r_E34071-000Pharmaceutical Marketing Businessreportable segmentrevenue2022-07-01 → 2022-09-30¥1.9bn
jpcrp040300-q1r_E34071-000Pharmaceutical Marketing Businessreportable segmentrevenue external2022-07-01 → 2022-09-30¥1.9bn
jpcrp040300-q1r_E34071-000Pharmaceutical Marketing Businessreportable segmentsegment profit2022-07-01 → 2022-09-30¥337m
—segment totalrevenue2022-07-01 → 2022-09-30¥5.9bn
—segment totalrevenue external2022-07-01 → 2022-09-30¥5.4bn
—segment totalrevenue intersegment2022-07-01 → 2022-09-30¥501m
—segment totalsegment profit2022-07-01 → 2022-09-30¥1.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 346
ItemContextValueUnit
Number of shares held in own name treasury shares etcCurrentQuarterInstant1300
Number of shares held in others names treasury shares etcCurrentQuarterInstant-
Total number of shares held treasury shares etcCurrentQuarterInstant1300
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0000
Cash and depositsPrior1YearInstant10767016000JPY
Cash and depositsCurrentQuarterInstant9574910000JPY
Notes and accounts receivable tradePrior1YearInstant3910453000JPY
Notes and accounts receivable tradeCurrentQuarterInstant4219983000JPY
Electronically recorded monetary claims operating caPrior1YearInstant4406195000JPY
Electronically recorded monetary claims operating caCurrentQuarterInstant5213939000JPY
Merchandise and finished goodsPrior1YearInstant1415639000JPY
Merchandise and finished goodsCurrentQuarterInstant1514914000JPY
Work in processPrior1YearInstant563125000JPY
Work in processCurrentQuarterInstant491750000JPY
Raw materials and suppliesPrior1YearInstant483358000JPY
Raw materials and suppliesCurrentQuarterInstant545339000JPY
Other caPrior1YearInstant284469000JPY
Other caCurrentQuarterInstant296443000JPY
Current assetsPrior1YearInstant21830258000JPY
Current assetsCurrentQuarterInstant21857281000JPY
Buildings and structuresPrior1YearInstant4889478000JPY
Buildings and structuresCurrentQuarterInstant4897723000JPY
Accumulated depreciation buildings and structuresPrior1YearInstant-2336069000JPY
Accumulated depreciation buildings and structuresCurrentQuarterInstant-2385200000JPY
Buildings and structures netPrior1YearInstant2553408000JPY
Buildings and structures netCurrentQuarterInstant2512522000JPY
Machinery equipment and vehiclesPrior1YearInstant3798624000JPY
Machinery equipment and vehiclesCurrentQuarterInstant3804129000JPY
Accumulated depreciation machinery equipment and vehiclesPrior1YearInstant-2267079000JPY
Accumulated depreciation machinery equipment and vehiclesCurrentQuarterInstant-2366005000JPY
Machinery equipment and vehicles netPrior1YearInstant1531544000JPY
Machinery equipment and vehicles netCurrentQuarterInstant1438123000JPY
Tools furniture and fixturesPrior1YearInstant1351945000JPY
Tools furniture and fixturesCurrentQuarterInstant1354353000JPY
Accumulated depreciation tools furniture and fixturesPrior1YearInstant-1085743000JPY
Accumulated depreciation tools furniture and fixturesCurrentQuarterInstant-1105783000JPY
Tools furniture and fixtures netPrior1YearInstant266201000JPY
Tools furniture and fixtures netCurrentQuarterInstant248569000JPY
LandPrior1YearInstant1761774000JPY
LandCurrentQuarterInstant1761774000JPY
Construction in progressPrior1YearInstant163026000JPY
Construction in progressCurrentQuarterInstant485414000JPY
Property plant and equipmentPrior1YearInstant6275955000JPY
Property plant and equipmentCurrentQuarterInstant6446405000JPY
Other iaPrior1YearInstant33879000JPY
Other iaCurrentQuarterInstant28237000JPY
Intangible assetsPrior1YearInstant33879000JPY
Intangible assetsCurrentQuarterInstant28237000JPY
Investment securitiesPrior1YearInstant56775000JPY
Investment securitiesCurrentQuarterInstant71372000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-06-30pass rounding
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-07-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-07-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-07-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-06-30pass
statement vs summary · total assetsconsolidated 2023-09-30pass